Sale!

Selling Sickness: How the World’s Biggest Pharmaceutical Companies Are Turning Us All Into Patients

Amazon.com Price:  $10.40 (as of 12/05/2019 17:19 PST- Details)

Description

Thirty years ago, Henry Gadsden, the head of Merck, one of the most world’s largest drug companies, told Fortune magazine that he wanted Merck to be more like chewing gum maker Wrigley’s. It had long been his dream to make drugs for healthy people in order that Merck could “sell to everyone.” Gadsden’s dream now drives the marketing machinery of probably the most profitable industry on the planet. Drug companies are systematically working to widen the very boundaries that define illness, and the markets for medication grow ever larger. Mild problems are redefined as serious illness and common complaints are labeled as medical conditions requiring drug treatments. Runny noses at the moment are allergic rhinitis, PMS has develop into a psychiatric disorder, and hyperactive children have ADD. In relation to conditions like high cholesterol or low bone density, being “at risk” is sold as a disease. Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt health-care systems all over the place the world. As an increasing number of of strange life becomes medicalized, the industry moves ever closer to Gadsden’s dream: “selling to everyone.”

Home » Shop » Books » Subjects » Engineering and Transportation » Engineering » Industrial, Manufacturing and Operational Systems » Manufacturing » Selling Sickness: How the World’s Biggest Pharmaceutical Companies Are Turning Us All Into Patients

Recent Products